GSK DCF Valuation - GlaxoSmithKline PLC - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

DCF Value

This DCF valuation model was created by Alpha Spread and was last updated on Oct 7, 2024.

Estimated DCF Value of one GSK stock is 62.49 USD. Compared to the current market price of 38.82 USD, the stock is Undervalued by 38%.

GSK DCF Value
Base Case
62.49 USD
Undervaluation 38%
DCF Value
Price
G
Worst Case
Base Case
Best Case
62.49
DCF Value
Worst Case
Base Case
Best Case
Hide
DCF Value: 62.49 USD

Present Value Calculation

This block is the starting point of the DCF valuation process. It calculates the present value of a company's forecasted cash flows based on selected operating model. Adjust key parameters like discount rate and terminal growth, and alter inputs such as revenue growth and margins to see their impact on valuation.

DCF Model
Base Case Scenario

The present value of cash flows over the next 5 years amounts to 27.2B GBP. The present value of the terminal value is 69.9B GBP. The total present value equals 97.2B GBP.
Forecast Period
Years
Discount Rate
%
Show All DCF Settings
Terminal Growth
%
Hide DCF Settings
Save

DCF Value Calculation

This stage translates the present value into DCF value per share. For firm valuation models, it adjusts present value for debt and assets to derive equity value (skipped if using equity valuation model). Finally, this equity value is divided by the number of shares to determine the DCF value per share.

Present Value to DCF Value
Capital Structure

Present Value 97.2B GBP
Equity Value 97.2B GBP
/ Shares Outstanding 2B
Value per Share 47.65 GBP
GBP / USD Exchange Rate 1.3113
GSK DCF Value 62.49 USD
Undervalued by 38%

You are using the equity valuation model. In this approach, further calculations for converting firm value to equity value are not required. The present value, obtained in the present value calculation block, already represents the equity value.

The DCF value per share is derived by dividing the present value by the number of shares:

Present Value
97.2B USD
/
Number of Shares
2B
=
DCF Value
62.49 USD

Valuation Analysis

Sensitivity Analysis
DCF Value Sensitivity Analysis

Sensitivity Analysis assesses how changes in key factors like revenue growth, margin, and discount rate affect a stock's DCF value. By visualizing various scenarios, from significant downturns to optimistic growth, this tool helps you understand potential valuation shifts, aiding in risk assessment and strategic decision-making.

DCF Financials
Financials used in DCF Calculation

Revenue
33.4B 42B
Net Income
6.8B 9.2B
FCFE
5.7B 7.9B

See Also

Discover More

What is the DCF value of one GSK stock?

Estimated DCF Value of one GSK stock is 62.49 USD. Compared to the current market price of 38.82 USD, the stock is Undervalued by 38%.

The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.

How was the DCF Value calculated?

1. Present Value Calculation. Utilizing the DCF operating model, GlaxoSmithKline PLC's future cash flows are projected and then discounted using a chosen discount rate to determine its Present Value, which is calculated at 97.2B GBP.

2. DCF Value Calculation. The company's capital structure is employed to derive the total Equity Value from the previously calculated Present Value of the cash flow. This Equity Value, when divided by the total number of outstanding shares, yields the DCF Value of 62.49 USD per share.

Back to Top
//